Related Experiment Video
Updated: Oct 3, 2025
06:54
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
2.9K
[Precision Medicine for Moyamoya Disease]
1Department of Neurosurgery, Hokkaido University Graduate School of Medicine.
No Shinkei Geka. Neurological Surgery
|February 16, 2022
Summary
RNF213 mutations are linked to Moyamoya disease (MMD) severity and onset. This gene may predict MMD clinical course and surgical outcomes, aiding precision medicine approaches.
Area of Science:
- Genetics
- Neurology
- Vascular Biology
Background:
- Moyamoya disease (MMD) is a chronic cerebrovascular condition causing artery stenosis and abnormal brain vessel networks.
- The exact cause of MMD remains unknown, but genetic factors are implicated.
Purpose of the Study:
- To investigate the role of the RNF213 gene in Moyamoya disease.
- To explore RNF213 as a potential biomarker for MMD prognosis and surgical outcomes.
Main Methods:
- Genetic analysis to identify RNF213 mutations in MMD patients.
- Correlation studies between RNF213 mutations and disease characteristics, including cerebral hemodynamics post-surgery.
Main Results:
- A specific RNF213 polymorphism (c.14576G>A) is found in 80% of Japanese MMD patients.
- RNF213 mutations correlate with earlier onset and increased disease severity.
- RNF213 mutations are associated with cerebral hyperperfusion after revascularization surgery in MMD patients.
Conclusions:
- RNF213 is a significant susceptibility gene for Moyamoya disease.
- RNF213 mutations may serve as a biomarker for predicting MMD clinical progression and surgical success.
- Further research is needed to elucidate the precise mechanisms of RNF213 in MMD pathogenesis and inform precision medicine strategies.
More Related Videos
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
133
10:30Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice
Published on: October 20, 2016
22.5K
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
34
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
34
01:25Mitral Regurgitation III: Medical Management
45
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
45
01:26Atherosclerosis III: Management
57
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
57
01:29Cardiomyopathy V: Interprofessional Care
56
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
01:21Rheumatic Heart Disease III: Medical Management
48
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
48
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K